Objective 
Introduction

The calcineurin inhibitor cyclosporin A (CsA) is a potent immunosuppressive agent that has formed the pharmacologic cornerstone of solid organ transplantation. Although pharmacologic studies of CsA have focused primarily on T cell responses, vascular injury has generally been considered a common important factor for all types of CsA-induced organ damage. The observation of multiple endothelial effects ment. The activation of EPCs is regulated by numerous cytokines and the most important family of cytokines implicated in the neovascularization processes is the vascular endothelial growth factor (VEGF) family. It has been shown that VEGF plays an important role in regulating EPC migration, homing, adhesion, proliferation, tubule formation, and differentiation
. CsA may differentially inhibit multiple steps in VEGF-induced angiogenesis, including the decrease of cell proliferation in human microvascular endothelial cells and human umbilical vein endothelial cells (1, 17) . (18, 19) . Estrogen was shown to increase the number of EPCs by its ability to induce NO (20) . The oxLDL inhibits eNOS activity and down-regulates eNOS expression, leading to a conspicuous decrease in NO generation, which may promote EPC apoptosis and poor overall function (21) . eNOS also contributes to the effect of VEGF in the improvement of EPC proliferation and function (18, 22, 23 
Previous studies have demonstrated that endothelial nitric oxide synthase/nitric oxide (eNOS/NO) is a significant regulator of angiogenesis. The absence of eNOS in mice has revealed impaired ischemia-induced angiogenesis and reduced EPC mobilization
Methods
Cell isolation and culture
The ex vivo expansion of EPCs was performed as described previously (6) 
t i o n wa s d e t e c t e d b y CCK-8 a s s a y . Re s u l t s s h o we d t h a t Cs A i n h i b i t e d E P C p r o l i fe r a t i o n i s d o s e d e p e n d e n t (
TUNEL assay for measuring apoptosis
Results
Characteristics of EPCs
The total MNCs were isolated and cultured for 7 d, resulting in spindle-shaped, endothelial cell-like morphology as described previously (6) 
CsA inhibits proliferation capacity of EPCs
The treatment with CsA decreased EPC proliferation in a dose-dependent manner (Fig. 1 (Fig. 2) .
CsA decreases eNOS mRNA and NO production in human EPCs
At the concentrations above 100 ng/mL, the CsA treatment markedly decreased eNOS mRNA expression (Fig. 3) and NO production (Fig. 4) 
in a dose dependent manner. Treatment with CsA (10 μg/mL) in the presence and absence of VEGF (50 ng/mL) decreased eNOS mRNA expression and NO production, and there was no significant differ-
T a b l e 1 . E f f e c t s o f Cs A, VE GF , a n d L -a r g i n i n e o n E P C P r o l i f e r a t i o n ( 4 5 0 n m L i g h t Ab s o r b a n c e ; − x ± s )
T a b l e 2 . E f f e c t s o f Cs A, VE GF , a n d L -a r g i n i n e o n E P C Nu mb e r ( − x ± s ) (29) (28) (34) (12, 13, 15, 16) . The CsA may differentially inhibit multiple steps in VEGF-induced angiogenesis including decreasing the proliferative capacity in mature endothelial cells (1, 17 As described previously, eNOS contributes to the effect of VEGF on the enhancement of EPC proliferation and func- (18, 22, 23 (35) (36) (37) . Rafiee et al (17) 
ence of eNOS/NO production between the CsA group and the CsA + VEGF group. Co-incubation with L-arginine (1 mM) and CsA (10 μg/mL) resulted in a higher production of NO, but not of eNOS mRNA, as compared with incubation with CsA alone (Figs. 3, 4).
Discussion
An immunosuppressant is necessary to prevent graft rejection after a solid organ transplant. However, it is also known to have significant side effects, including endothelial toxicity. The growth of new microvessels (or angiogenesis), and the re-endothelialization of impaired endothelium, is now considered to be a critical biologic process involving EPCs. The effect of CsA treatment on EPC number is controversial from previous studies. Davies et al (28) indicated that CsA, even at concentrations lower than therapeutic levels (10-200 ng/mL), potently decreased cell number by inhibiting EPC proliferation. However, Miriuka et al
showed that CsA treatment deceased colony forming units of EPCs (it represents the number of EPCs) from peripheral blood of swine received either cardiac transplantation or sham operation. Inversely, the work of Wang et al (34) showed that the number of circulating EPCs was markedly increased by the CsA treatment in mice of ischemic limb models by way of inhibiting the activity of CD26/DPP IV (dipeptidylpeptidase IV) system. This contributed to the increased concentrations of stroma-derived factor-1α (SDF-1α) and stem cell factor (SCF). Interestingly, Wang et al
t a t i v e p h o t o g r a p h s a r e g i v e n . Gr e e n , T UNE L p o s i t i v e ; b l u e , s t a i n i n g o f n u c l e i wi t h DAP I . B a r c h a r t s h o ws t h a t t h e e f f e c t o f Cs A o n E P C a p o p t o s i s i s d o s e d e p e n d e n t , a n d c o -i nc u b a t i o n wi t h Cs A a n d L -a r g i n i n e c o mp l e t e l y a b r o g a t e d t h e e f f e c t o f Cs A o n E P C a p o p t o s i s (
F i g u r e 3 . T h e e f f e c t o f Cs A t r e a t me n t o n t h e e x p r e s s i o n o f e NOS g e n e i n E P Cs . T h e mRNA o f e NOS we r e a mp l i f i e d b y RT -P CR; s a mp l e s we r e v i s u a l i z e d o n 2 % a g a r o s e g e l s u s i n g e t h i d i u m b r o mi d e . T h e b a r c h a r t s h o ws s e mi q u a n t i t a t i v e a n a l y s i s o f b a n d i n t e n s i t y o f RT -P CR. T h e r a t i o o f i n t e g r a t e d o p t i c a l d e n s i t y ( I OD) f r o m e NOS mRNA b a n d t o GAP DH mRNA b a n d wa s c a l c u l a t e d . T h e d a t a we r e s h o wn a s p e r c e n t a g e o f t h e d a t a f r o m c o n t r o l g r o u p . T h e e f f e c t o f Cs A o n t h e e xp r e s s i o n o f e NOS g e n e i s d o s e d e p e n d e n t . S t i mu l a t i o n wi t h VE GF p r o mo t e d e NOS e x p r e s s i o n wh i c h wa s c o mp l e t e l y a b r o g a t e d b y Cs A. T r e a t me n t wi t h L -a r g i n i n e f a i l e d t o c h a n g e e NOS
F i g u r e 4 . T h e e f f e c t o f Cs A t r e a t me n t o n t h e p r o d u c t i o n o f NO g e n e r a t i o n i n E P Cs . T h e p r o d u ct i o n o f NO wa s a s s a y e d b y t h e Gr i e s s me t h o d . T h e d a t a we r e s h o wn a s p e r c e n t a g e o f c o n t r o l g r o u p . B a r c h a r t s h o ws t h a t t h e e f f e c t o f Cs A o n NO p r o d u c t i o n i s d o s e d e p e n d e n t , a n d c o -i n c u b at i o n wi t h Cs A a n d L -a r g i n i n e s i g n i f i c a n t l y i n c r e a s e d NO p r o d u c t i o n a s c o mp a r e d wi t h Cs A a l o n e . S t i mu l a t i o n wi t h VE GF p o t e n t l y p r o mo t e d NO
